News
NewS Releases
May 6, 2025: Eden Radioisotopes and Cross River Infrastructure Partners Sign MOU to Explore Development of a New Generation Medical Radioisotope Reactor in New Brunswick
Eden Radioisotopes, LLC ("Eden") and Cross River Infrastructure Partners, LLC ("CRIP") are pleased to announce the execution of a Memorandum of Understanding (MOU) to jointly explore the development of a new nuclear medical radioisotope reactor and hot cell processing facility in the Province of New Brunswick, Canada...
May 22, 2019: Eden Radioisotopes, LLC, Secures Reactor Project Funding for Medical Isotope Production
Eden Radioisotopes, LLC, an Albuquerque, NM startup company, is pleased to announce an investment agreement with Abo Empire, LLC, a Yates Family company. This investment funds the company project to build a reactor of less than 2MW in New Mexico for the purpose of producing medical isotopes, primarily Molybdenum-99. Known as Moly-99 for short, this isotope is a critical raw material for Technetium-99m, used extensively in medical molecular imaging, also known as ...
May 22, 2019: Eden Radioisotopes, LLC, Secures Reactor Project Funding for Medical Isotope Production
Eden Radioisotopes, LLC, an Albuquerque, NM startup company, is pleased to announce an investment agreement with Abo Empire, LLC, a Yates Family company. This investment funds the company project to build a reactor of less than 2MW in New Mexico for the purpose of producing medical isotopes...
Nov 21, 2019: Eden Radioisotopes, LLC and Sandia National Laboratories Earn 2019 Technology Transfer Award From the Federal Laboratory Consortium
Eden Radioisotopes, LLC, an Albuquerque, NM, startup company, and Sandia National Laboratories earned a regional Federal Laboratory Consortium (FLC) award recognizing federal laboratories and their partners for outstanding work to develop and commercialize innovative technologies.